The carcinogen benzoapyrene (BAP) can also induce PD-L1 expression in pulmonary epithelial cells in vitro and in vivo, and PD-1 inhibitors can significantly inhibit BAP-induced lung cancer [125]. Here, CD274 is linked to lung carcinoma.